Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Subordinated Debt and Hybrid Capital in Insurance

Abstract. Subordinated debt and hybrid securities occupy a distinctive position in insurance finance: they are legally enforceable claims constructed to absorb a specified degree of loss and, subject to supervisory conditions, to supplement the capital resources available to support policyholder obligations. This monograph examines their contractual structure, credit hierarchy, coupon discretion, redemption constraints, prudential treatment, accounting classification, refinancing economics, and implications for the financial resilience of insurers and insurance groups. It synthesizes primary rules under the European Union's Solvency II regime, the International Association of Insurance Supervisors' Insurance Capital Standard, the United States' statutory surplus-note and risk-based-capital arrangements, and the United Kingdom's developing Solvency UK requirements. Public 2025 issuances by AXA, Allianz, Generali, and Zurich provide carefully bounded transaction evidence. Quantitative illustrations clarify eligibility limits, claims priority, the cost of contingent coupon flexibility, spread sensitivity, and group-capital double-counting. The principal conclusion is that an instrument's contribution to solvency depends jointly on the legal placement of its claim, the enforceability and timing of loss-absorbing features, the insurer's liquidity, the relevant regulatory measurement system, and the terms under which investors are compensated. Prudential recognition, accounting presentation, economic capital and cash-funded claims-paying capacity require independent analysis before their conclusions can be integrated. The manuscript offers an original comparative and financial interpretation of established frameworks; it neither establishes a new scientific theory nor claims an empirical causal estimate.

Keywords: Subordinated debt; insurance hybrid capital; Solvency II; restricted Tier 1; Tier 2; insurance capital resources; Insurance Capital Standard; IAIS; surplus notes; NAIC; loss absorption; coupon deferral; write-down; policyholder protection; solvency capital requirement; minimum capital requirement; maturity; refinancing; structural subordination; insurer liquidity; capital fungibility; IAS 32; cost of capital; investor risk; Solvency UK.

Introduction

The financial promise of an insurance contract is made long before the ultimate amount and timing of many claims are known. Premium revenue and invested assets support technical provisions and capital resources whose adequacy is evaluated under solvency regulations. Capital instruments therefore have two interacting purposes: they finance the undertaking and determine who bears adverse outcomes when assets or earnings prove insufficient. Subordinated debt and hybrids turn this second purpose into explicit legal terms.

The object of this study is a security or contractual funding commitment issued by an insurer or an insurance group whose payment priority and loss-absorption features are designed with reference to insurance supervisory requirements. Senior bonds, ordinary shares, mutual-member contributions, insurer-held investment bonds, and reinsurance are addressed where their relationships clarify this object. Classification of all capital instruments is the distinct subject of the related research on Insurance Capital Tiers and Loss-Absorbing Instruments. Here the emphasis rests on the contractual and financing properties of subordinated instruments, their eligible capital contribution, and the distribution of risk between the issuer, policyholders and investors.

The institutional distinction matters. The European Union's Solvency II legal framework assesses eligible own funds against both the Solvency Capital Requirement (SCR) and the Minimum Capital Requirement (MCR). The International Association of Insurance Supervisors (IAIS) developed an Insurance Capital Standard as a prescribed group-capital benchmark for internationally active insurance groups, with national supervisory implementation remaining indispensable. The United States uses statutory financial reporting and state insurance supervision, including surplus-note restrictions that produce outcomes markedly different from ordinary issuer-debt accounting. These systems share an interest in policyholder security while applying their own definitions, eligible-resource calculations, and supervisory powers.

This manuscript uses a documentary method. Binding provisions and supervisory statements establish the conditions actually governing securities. Official issuer announcements establish described transaction features and announced purposes, without substituting for their full final prospectuses. Scholarly articles provide explanatory hypotheses about capital decisions and debt incentives; abstracts and bibliographic records are used only within their accessible scope. Hypothetical arithmetic demonstrates the operation of a rule and never purports to reproduce an actual company's balance sheet. Regulatory comparisons use a research cutoff of November 15, 2026, and distinguish provisions already operating from changes scheduled for 2027.

The central research questions are how debt-like securities may acquire solvency-recognized loss-bearing properties; which clauses determine whether they remain usable during stress; when their apparent capital contribution becomes constrained by tier limits and group structure; how investor pricing reflects deferral, call and principal risks; and what public transactions can support by way of comparative inference. Every conclusion is connected to an identified regulatory, documentary, scholarly or explicitly hypothetical premise.

Subordinated Insurance Liabilities

Economic and legal nature of the instrument

A conventional loan finances the borrower in exchange for a promise to pay principal and interest according to agreed conditions. A subordinated loan adds a ranking arrangement under which payment of its claim is deferred behind specified other claims in insolvency or liquidation. Insurance capital securities may impose additional conditions, including restrictions on interest payment, extended maturity, supervisory consent for redemption, and direct write-down or conversion following financial deterioration. Each of these changes the allocation of losses and cash-flow discretion. They also change the price that investors will generally demand.

Legal subordination should be examined through the actual instrument documentation and the insolvency law applicable to the obligor. It does not inherently ensure that a note is eligible as regulatory capital. An instrument can rank below policyholder claims but fail the applicable permanence condition, contain an impermissible acceleration clause, or have already exhausted the issuer's tier-recognition capacity. Conversely, a perpetual or equity-accounted instrument may still fall short of regulatory criteria if a contractual guarantee transfers losses to another entity or if payments create an excessive risk of insolvency.

For EU insurers, the Tier 2 feature requirements illustrate how detailed the qualification test becomes. The rule requires a qualifying item to rank behind claims of policyholders, beneficiaries and non-subordinated creditors; to avoid terms that cause or accelerate insolvency; and to possess a minimum original maturity or indefinite life together with restrictions on redemption and distributions. The instrument's legal claim thus has to be read with its callable features and the legal constraints on management's actions.

An instrument is simultaneously an investment asset for the buyer and a financial obligation or capital resource for the issuer. Investors assess probability of default, recovery hierarchy, interest deferral, the reset basis and likely secondary-market liquidity. Policyholders depend on the same hierarchy from the opposite direction: where subordination operates as intended, subordinated holders absorb a specified layer of deterioration ahead of policyholder and ordinary-creditor shortfalls. The position cannot be evaluated from the coupon percentage alone.

Priority, insolvency waterfall and policyholder interests

Priority defines the order in which the debtor's realizable assets are allocated among creditors when their aggregate claims exceed available value, subject to applicable statutory priorities and costs. In a simplified sequence, secured claims and insolvency expenses receive their legally prescribed treatment, policyholder and other senior claims follow according to governing law, eligible subordinated creditors bear losses after those higher claims, and shareholders bear the residual economic loss. Real insurance insolvencies can involve statutory policyholder preference, guaranty arrangements, multiple licensed entities and cross-border creditor rights, so a single universal waterfall would be incorrect.

The relevant EU Tier 1 loss-absorption requirements demonstrate that different subordination positions exist even within regulated capital. Restricted Tier 1 securities can rank behind Tier 2 and Tier 3 items and senior policyholder and creditor claims. Their additional capacity to absorb loss while the undertaking continues operating represents a further feature beyond mere subordination in liquidation. The economic benefit is conditional on those legal clauses working in the situations for which they were written.

Suppose a single fictional insurer has realizable assets of 1,000 accounting units, aggregate policyholder and non-subordinated claims of 900 and subordinated claims of 150, with no other legally relevant class. Senior claimants receive 900 and subordinated creditors receive the remaining 100, a loss of 50 against subordinated principal. If realizable assets instead fall to 800, subordinated creditors receive zero and senior creditors divide 800 against their 900 claims. The first 150 of shortfall below total creditor claims is borne by subordinated creditors; sufficiently severe losses still reach senior stakeholders. The numerical example establishes an order of claims, not a probability distribution or a legal characterization of any actual jurisdiction.

This distinction separates capital quality from capital sufficiency. More subordination can reduce the severity or likelihood of a policyholder shortfall under a specified balance-sheet state, yet neither the note's face value nor a percentage solvency ratio alone proves that invested assets will be liquid when claims fall due. Credit risk, liquidity risk and operational resilience remain connected but distinct.

Standalone insurer and holding-company issuance

A subordinated security may be issued by the insurance undertaking that writes policies, by a holding company above it, or by a finance subsidiary with a guarantee from another group entity. These arrangements determine which legal pool of assets stands behind investors' claims. At an insurance holding company, obligations can be structurally subordinated to creditors of operating subsidiaries because holding-company investors receive value principally through dividends, repayments or distributions from those subsidiaries after local obligations are satisfied. Structural subordination depends on actual entity relationships and enforceable transaction terms; it should never be inferred solely from a consolidated group label.

The IAIS ICS Online Tool approaches capital through the internationally active insurance group's balance sheet and identified capital resources. A group-issued obligation that finances paid-in capital at an operating insurer presents at least two analytical layers: the group has an external claim owed to a noteholder, while the subsidiary receives additional equity or another qualifying asset. Consolidation removes the intercompany investment and corresponding subsidiary equity to the extent required by the consolidation method. The external note's regulatory inclusion must then be assessed at the proper group level using its own terms.

For illustration, a holding company issues 100 units of external subordinated debt and subscribes for 100 units of ordinary equity in a regulated subsidiary. The subsidiary's standalone ordinary equity may increase by 100, subject to valuation, actual funding and supervision. Group-level eligible capital cannot automatically be increased by 200: the internal subscription is eliminated on consolidation, and the external note contributes only to the extent it independently meets group-capital criteria. The example captures a basic accounting constraint, not a novel capital model.

Cross-border groups add fungibility risk. Capital recognized at a subsidiary may be restricted by local capital buffers, ring-fenced assets, distribution permission, minority interests, exchange controls or resolution actions. A note issued in one jurisdiction cannot be evaluated as if all group assets are immediately and unconditionally available to every policyholder in every jurisdiction.

Regulatory versus financial-reporting identity

The same instrument may receive different classifications under prudential regulations, statutory insurance accounting, financial-reporting standards and credit-agency methodologies. Under the IFRS Foundation's IAS 32 classification framework, a key distinction between a financial liability and an equity instrument is the contractual obligation to deliver cash or another financial asset, with further analysis required for contingent settlement and compound instruments. A debt security designed to count as Tier 2 own funds need not appear as ordinary accounting equity. A restricted Tier 1 hybrid requires its particular payment and principal clauses to be analyzed before any accounting conclusion is possible.

The NAIC's surplus-note accounting explanation provides a striking institutional contrast. An admitted U.S. insurer's qualifying surplus note is treated as surplus under statutory accounting principles, although U.S. generally accepted accounting principles characterize it as debt. The note is subordinated to policyholders and other creditors, and issuance and payments of principal or interest require approval from the domiciliary insurance commissioner. These accounting and supervisory characteristics are not interchangeable with the terms of EU Tier 2 notes.

Three analytical quantities therefore have to be specified independently: the liability or equity figure reported under a named accounting framework; the capital amount admitted into a named supervisory formula; and the security's economic market value. Equality among them is a special result requiring proof, not a reasonable default. Differences can arise from limits on eligible tiers, valuation adjustments, cumulative unpaid coupons, embedded options, and market repricing when the issuer's credit risk changes.

Historical rationale and scholarly foundations

Insurer capital structure is endogenous to underwriting risk, investment risk and access to new funds. Cummins and Sommer (1996), in their capital-and-risk empirical study, analyze capital and portfolio risk jointly and report evidence consistent with linked decisions. That result motivates examination of the insurer's asset and liability risk when assessing its borrowing, rather than treating observed capitalization as an isolated financing preference. The study does not itself identify the effect of any particular 2025 hybrid security, and its historical sample cannot be transferred uncritically to later supervisory arrangements.

Myers (1977), through his analysis of corporate borrowing, explains how risky outstanding debt can influence investment incentives and the division of project value between equity and lenders. Insurance groups face related, institution-specific tensions when debt service competes with recapitalization or when asset sales would damage the insurer's future ability to meet policy obligations. The theoretical mechanism is informative, while its application requires the additional constraints imposed by insurance supervision.

Organizational form matters. Harrington and Niehaus (2002), in their study of stock and mutual insurers, examine different costs of raising capital and the sensitivity of capitalization to income. Mutual insurers often have a more restricted access route to new ordinary equity than publicly traded stock insurers; this gives hybrid and surplus-note instruments particular practical relevance. The applicability of their empirical sample to a contemporary mutual is a question for separate issuer-specific evidence.

Taken together, these studies support a grounded proposition: subordinated financing is chosen within a wider strategy involving risk appetite, capital access, organizational form, supervisory constraints and the relative cost of claims-bearing funds. The particular legal performance of each instrument remains decisive.

Hybrid Security Contract Terms

Governing documents and the term-sheet hierarchy

A credible assessment begins with the issuer's organizational structure, offering documentation, final terms and the law governing the security. An investor presentation or press release gives a convenient summary but may omit acceleration exceptions, capitalization definitions, regulatory event provisions, tax gross-up clauses, substitution rights, further-issue provisions and contractual trigger mechanics. When those omitted provisions affect legal outcomes, the final prospectus, trust deed, fiscal agency agreement and related guarantee must take priority over a marketing summary.

The information needed for a full contract review can be organized as a term-sheet audit: legal issuer and guarantor; currency and principal amount; issue and settlement dates; maturity and first possible call; interest type and reset formula; ranking and events of default; trigger definition and measurement entity; loss-absorption sequence; coupon cancellation or deferral; accumulated interest claims; redemption permissions; regulatory-disqualification events; tax conditions; and governing-law and resolution clauses. The purpose of this audit is reproducibility. Two securities bearing the name “subordinated” should not be treated as equivalent until their substantive terms are compared.

A contract may also contain multiple regulatory representations. An issuer statement that an instrument “qualifies” as restricted Tier 1 or Tier 2 describes a particular supervisory treatment as presented at issuance, generally within applicable limits. It does not guarantee permanent eligibility across all future changes in regulation or after changes to the undertaking's recognized capital stack.

Maturity, calls, optional redemption and step-ups

Term maturity determines when principal is contractually due, while a call gives the issuer a right to repay earlier under stated conditions. A first-call date is therefore an option boundary rather than a repayment commitment. EU Tier 2 Article 73 conditions generally require an original maturity of at least ten years for dated qualifying items, a first contractual opportunity to redeem no earlier than five years from issuance, issuer-option redemption and prior supervisory approval. Limited incentives to redeem are constrained by timing and amount. Tier 1 items instead emphasize stronger permanence and more immediate loss absorption.

A fixed-to-floating or fixed-to-reset coupon can make the first-call date economically salient. Suppose an instrument pays a fixed coupon during its first decade and afterward resets to a market benchmark plus a defined spread. If market interest rates and issuer credit spreads have changed, the cost of leaving the bond outstanding may exceed or fall below the cost of replacement. Management must additionally consider supervisory consent, capital requirements, tax implications, investor relations and its continued market access.

The distinction between a contractual maturity and expected maturity is central to valuation. Investors often price callable subordinated bonds to an assumed call, but this assumption is vulnerable precisely when capital markets become less accessible. A higher post-call coupon does not by itself guarantee exercise, and treating an expected call as a binding payment date understates tail maturity risk.

An early-redemption incentive may take many forms: a scheduled step-up, a spread increase or a commercial arrangement that imposes a material penalty if the issuer keeps the note outstanding. Supervisory rules constrain incentives because a security expected to leave the capital structure at the first economically plausible opportunity contributes less reliable permanence. The actual contractual spread change should be compared with the relevant version of the rule rather than judged from generic market practice.

Deferral, cancellation and contractual acceleration

Coupon deferral postpones a payment and can preserve cash during stress. Cancellation extinguishes or removes a scheduled distribution in accordance with the security terms. The two mechanisms carry different investor and issuer consequences. If a deferred coupon remains a cumulative debt claim, it may burden future cash flows and contribute to an accounting liability. If an instrument permits noncumulative discretionary cancellation, the scheduled interest may cease to be owed in the specified circumstances. Either mechanism requires attention to alternative coupon-payment obligations, parity securities, dividend-stopper provisions and any regulatory prohibition.

A conventional senior bond typically creates a default or enforcement response to missed contractual coupons. A qualifying insurance capital instrument is expected to contain deferral or cancellation rights compatible with the supervisory capital purpose. EU Tier 1 Article 71 features include restrictions on distributions and loss-absorption machinery, while Tier 2 Article 73 addresses the deferral of distributions during SCR noncompliance and other conditions. The precise circumstances for voluntary versus mandatory coupon restrictions differ by tier and contractual category.

Acceleration clauses can erode subordination. A demand for immediate repayment following a missed coupon may transform temporary cash pressure into a broader liquidity crisis. Eligible capital rules consequently pay attention to provisions that could cause or accelerate insolvency. Investors must test not only whether they can sue but when and to what extent enforcement can produce payment from assets otherwise protecting policyholders.

Replacement, regulatory events and capital-quality consequences

Instrument documentation frequently contemplates changes in tax treatment, regulation or rating methodology, subject to its own conditions. A security may cease to qualify fully for a desired tier following amendments to supervisory rules or changes to the issuer's classification. The issuer may then seek supervisory approval for redemption, replacement or contract modification. Such a feature can transfer reinvestment risk to the investor if the note is redeemed when replacement market yields have fallen, or leave the issuer carrying a costlier instrument when permission or market conditions prevent a call.

Replacement capital is not a purely numerical concept. New securities may differ in loss absorbency, maturity, ranking and legal issuer. Replacing Tier 2 with nominally equal senior debt can preserve some financing but reduce eligible capital. Replacing one subordinated issue with another of similar face value may still alter the composition of recognized own funds, particularly when the old issue had reached its limit or the new issue introduces more reliable coupon discretion.

Policyholder security also depends on transaction costs and the time at which a replacement is funded. A planned redemption before replacement settlement can temporarily reduce capital resources and liquidity. Effective supervision is therefore part of the economic substance of the security, not a procedural afterthought.

Currency, governing law and resolution

The instrument's currency can differ from the insurer's principal claims currency, while its interest reset benchmark can be tied to a different yield curve. In a multinational insurance group, a euro security may finance a portfolio with dollar claims and sterling assets. Currency swaps may reduce some exchange-rate exposures but introduce counterparty margin needs, collateral calls and basis risk. The security's funding coupon is only one component of the all-in hedged cost.

The legal hierarchy must be identified in relation to the issuer's domicile, applicable insolvency and insurance laws, terms of guarantee and resolution measures. Whether courts or supervisors can write down, suspend or restructure a claim cannot be established merely by copying the description of another issue. Jurisdiction-specific policyholder preferences, recognition of foreign orders and insurer winding-up procedures shape enforceability.

For the researcher, the final question is operational: under which concrete adverse event does the security cease to require a cash payment or bear a reduction of principal, and who can enforce that result? Answering it requires the interaction of the contract, the supervisor's authority and the entity-level balance sheet.

Coupon Deferral and Loss Absorption

Loss allocation during ordinary operations and distress

Capital quality can be understood through the states in which a security changes the issuer's obligations. In normal operations, subordinated debt supplies funding in exchange for scheduled cash distributions and a future repayment claim. Under financial pressure, its value to the insurer depends on which obligations become discretionary, deferable, reducible or payable only with permission. At insolvency, ranking determines its place in creditor recoveries. These are related but distinct stages of the security's life.

A conventional subordinated note mainly offers protection through its low repayment rank after winding-up. Restricted Tier 1 securities may add mechanisms that diminish principal claims while the issuer remains a going concern. The EU's Article 71 Tier 1 conditions require certain relevant items to absorb losses through a prescribed principal mechanism and impose rules on distributions. A security cannot demonstrate the required principal loss absorbency merely by promising to stop coupon payments. The contractual amount on which the investor can ultimately claim repayment must be affected according to the applicable regulatory and legal mechanism.

The economic measure of loss absorption is consequently multidimensional. Senior-creditor protection depends on the hierarchy of claims in resolution. Day-to-day liquidity protection depends on whether coupons and calls can be withheld without creating immediate acceleration or insolvency. Reported solvency protection depends on whether the relevant prudential regime recognizes the security and how the recognition behaves under stress. A capital instrument may perform strongly in one dimension and weakly in another.

Going-concern conversion or write-down

Write-down reduces the contractual principal amount, temporarily or permanently under terms specified in the security, while conversion exchanges the security into a designated form of equity or other qualifying capital. Either can shift losses from ordinary policyholder-supporting resources onto a junior funding layer before a formal liquidation. The investor bears substantial principal risk and may lose expected future distributions. The issuer's result depends on the legal effect of the reduction and the supervisory treatment of the instrument after the event.

The EU significant-noncompliance trigger for specified Tier 1 instruments includes three alternatives: eligible own funds for SCR coverage at or below 75 percent of the SCR; eligible own funds for MCR coverage at or below the MCR; or SCR compliance remaining unrestored three months after initial noncompliance. Applicable terms may specify additional triggers. These tests should be read as legal thresholds under a specific instrument category, not as a universal description of every EU insurance note.

Write-down provisions have several design choices that materially change investor risk. A reduction may be permanent or subject to conditional reinstatement. A nominal reduction may affect accrued interest, subsequent coupon bases and ranking against other securities. Conversion can require a prescribed share-issuance mechanism and dilution of existing shareholders. A holding-company security may be triggered by metrics at the parent, an operating subsidiary or both, depending on the document. The consequence for existing policyholders is determined by actual balance-sheet capitalization and the continuing availability of operating capital.

A purely hypothetical example shows the difference. Assume an insurer has 700 units of available eligible Tier 1 capital and 300 of other eligible resources supporting an SCR of 1,000. A severe adverse event reduces eligible resources to 740 while the SCR stays constant. Its resulting ratio is 74 percent and lies below the 75 percent threshold relevant to the specified EU restricted Tier 1 trigger. If a 100-unit hybrid contract then validly writes down 60 units of principal, the investor has lost 60 units of its claim. The accounting and supervisory effect cannot be inferred to be an automatic 60-unit increase in measured eligible own funds: the pre-trigger treatment, fair-value effects, remaining note recognition, tax implications and recalculation of available capital have to be modeled consistently. The purpose of the illustration is the investor-loss mechanism, rather than a claim about a regulatory ratio automatically repaired by nominal write-down.

Distribution deferral and liquidity

Distribution flexibility carries direct cash-flow value when the issuer encounters an adverse claims period, an investment loss, or unexpectedly high collateral demands. A fictional €200 million issue with a 6 percent fixed annual coupon would otherwise require €12 million in cash each year. Deferring an allowed payment for one year preserves €12 million of cash at the original payment date. Whether it reduces recognized liabilities or merely postpones a payable amount depends on contractual accumulation and accounting rules. A cancellation right, if effectively exercised under the contract, can change the issuer's payment obligation in a different way.

An investor should separate the coupon's stated rate from its expected realizable payments. A six percent coupon is a contractual calculation basis, not a guaranteed six percent annual cash receipt under a discretionary-cancellation structure. The investor's expected return reflects the joint distribution of market rates, issuer solvency, exercise of cancellation rights, principal impairment, potential recovery and the realized redemption date.

Supervisory restrictions can be mandatory even when the issuer would prefer to distribute funds. The Article 73 distribution provisions require qualifying Tier 2 contracts in relevant categories to permit deferral where SCR noncompliance exists or a distribution would cause it, subject to their applicable rules and exceptions. The structure prevents an otherwise valuable regulatory capital layer from generating an unconditional cash drain at the moment its support is most necessary.

The decision to defer may produce feedback effects. Investors can interpret suspension as adverse information, demanding higher yields on subsequent issuance. Rating agencies and counterparties may reassess the issuer's funding position. Management therefore considers both the immediate liquidity benefit and prospective market-access costs. These effects are economically material yet depend on circumstances and cannot be represented as a fixed penalty embedded in the regulation.

Priority-waterfall calculations

For transparent calculation, consider two simplified insolvency cases expressed in monetary units, ignoring expenses and differences in national statutory preference. There are 900 units of policyholder and other senior unsecured claims, 150 units of subordinated note principal, and ordinary equity beneath those claims.

Assumed recoverable assets Senior recovery Subordinated recovery Subordinated principal loss Senior claim shortfall
1,100 900 150 0 0
1,000 900 100 50 0
950 900 50 100 0
900 900 0 150 0
800 800 0 150 100

At 1,100 units, the final 50 belong to the residual equity interest in the assumed absence of other obligations. At 1,000, subordinated creditors lose one third of principal while seniors are fully covered. At 800, all subordinated principal is eliminated and senior claimants still face a 100-unit deficit. The recovery order follows from assumptions, and the illustration does not assign insured priority within the aggregate senior category. It demonstrates that junior debt improves loss distribution between creditor classes without making the claims-supporting asset pool invulnerable.

If the security instead has a legally operative going-concern write-down, relevant losses may be allocated earlier. That timing can preserve contractual resources available to the insurer before formal winding-up, but it is subject to the exact trigger and the operational solvency position. The financial meaning of “loss-absorbing” should therefore always be accompanied by an answer to the question “at what point, through which legal action, and against which balance sheet?”

Simplified stress and sensitivity tests

Stress analysis for insurance capital securities should begin with the insurer's underlying risks and only then layer funding effects onto them. Typical shocks include catastrophic claims, reserve strengthening, adverse mortality or longevity developments, corporate credit defaults, a parallel yield-curve movement, a sovereign spread widening, exchange-rate dislocation and collateral calls. The set must be selected according to the insurer's underwriting liabilities, asset portfolio and business model; a life insurer with long-duration guarantees does not share the same dominant exposures as a short-tail property insurer.

For a fixed-rate funding obligation, annual contractual cost equals outstanding principal multiplied by the coupon rate until the applicable reset. A €500 million subordinated instrument paying 200 basis points more than an otherwise feasible comparator costs €10 million more per full coupon year before tax, fees and derivative costs. For ten annual payments discounted at a hypothetical constant 5 percent, the present value of this difference is approximately €77.217 million. This is a scenario sensitivity, not an observed market premium for Tier 2 eligibility; the securities compared may differ in maturity, loss absorption and investor claims, making a simple spread difference an imperfect measure of “capital cost.”

Principal impairment must be stress-tested as a separate claim. Suppose a 200-unit issue has a 30 percent unconditional write-down under the assumed stress. The amount of principal removed from the investor's claim is 60 units, leaving a claim of 140 before any contractual reinstatement. If a second stress requires a further write-down based on the then-outstanding 140, a further 30 percent equals 42, not 60. The arithmetic demonstrates why sequential triggers and replenishment provisions must be specified before reporting stress outcomes.

A cash-flow stress also examines whether a coupon is payable at the time of the adverse event. If a €12 million coupon would have been due in the month of a catastrophe and the issuer validly cancels it, immediate liquidity is higher by €12 million than in the otherwise identical payment scenario. If cancellation leads to market-access impairment that increases funding costs by €20 million during a refinancing, the longer-horizon consequence may differ. A complete analysis requires the probability, timing and legal feasibility of both outcomes, which this hypothetical example deliberately leaves unspecified.

Accounting and investor interpretation

The amount of principal eliminated is not necessarily identical to an immediate accounting profit or a fully eligible capital increase. The measurement may depend on the security's initial financial-liability or equity classification, applicable accounting standards, the current value of the claim and interaction with tax effects. The IAS 32 financial-instrument rules explain why the contract's obligation to deliver cash matters in deciding financial-statement classification. Separate measurement requirements may arise under other IFRS standards.

Investors should also avoid treating the supervisor as a guarantor of subordinated securities. Regulatory restrictions are designed to protect policyholders, and those restrictions can reduce payments to junior creditors. This is especially clear in the United States, where the NAIC surplus-note description specifies commissioner approval for principal and interest and explains that withholding approval is not necessarily a contractual default under the note. A publicly traded surplus note can accordingly experience substantial market repricing even if the insurance undertaking remains operational.

The synthesis is that cancellation risk, write-down risk, deferral risk and liquidation-recovery risk are different state-dependent exposures. They may coincide in an acute insurance shock, and each should be evaluated against the same financial scenario to avoid double-counting losses or incorrectly treating cash preserved by a delayed coupon as new permanent capital.

Supervisory Tier Eligibility

European Union: quality and quantitative ceilings

Solvency II distinguishes basic own funds from eligible ancillary commitments and classifies items by their availability, subordination, permanence and ability to absorb losses. Specific qualifying items are recognized within a supervisory tier, and tier ceilings then constrain how much of each category may cover the SCR or MCR. Legal issuance of a security, its inclusion in the basic-own-funds inventory, and its inclusion in the amount eligible for a particular capital requirement are different steps in the calculation.

Under the EU Tier 1 feature framework, the most durable and loss-absorbing resources receive the strongest quality status. Securities with more limited loss absorption and appropriate subordination may instead meet Tier 2 recognition conditions. An instrument with insufficient quality for either category does not become eligible simply because its interest is expensive or investors view it as highly risky. Regulatory quality is specified by the rules and the contract.

The quantitative limits stated in Solvency II Article 82 establish that eligible Tier 1 must be at least half of the SCR; eligible Tier 3 is less than 15 percent of the SCR; and Tier 2 plus Tier 3 may not exceed 50 percent of the SCR. For MCR coverage, eligible Tier 1 must be at least 80 percent of MCR, with Tier 2 capped at 20 percent of MCR. Certain restricted Tier 1 instruments must also form less than 20 percent of the relevant Tier 1 total. The strict “less than” signs matter at boundary values, and restrictions can interact with transitional treatment.

These are admissibility ceilings, not targets for the maximum economically prudent leverage of an insurer. A Tier 2 bond that fits under the legal limit may still make the group less flexible because its interest must be financed in normal conditions, its first-call expectation affects market confidence, or the entity's liquidity buffer is deficient. The amount legally counted is one input to a wider solvency assessment.

SCR versus MCR calculations

Consider a wholly fictional European insurer with SCR of 1,000 monetary units and MCR of 400. Assume 700 units of qualifying Tier 1, including 120 units of eligible restricted Tier 1, 550 units of qualifying Tier 2, and 120 of qualifying Tier 3. Assume all items pass their qualitative tests, no additional ring-fencing or availability constraints apply, and the restricted Tier 1 share falls within its applicable ceiling because 120 divided by 700 is approximately 17.14 percent.

Under the SCR test, Tier 3 of 120 is below 15 percent of the SCR. The combined eligible Tier 2 and Tier 3 maximum is 500, so with Tier 3 set at 120 the eligible Tier 2 amount cannot exceed 380. Recognized capital for SCR coverage is therefore 700 + 380 + 120 = 1,200 units, and the simplified coverage ratio is 120 percent. The undertaking actually has 1,370 of the three gross listed categories, but 170 is excluded from the SCR numerator by the assumed tier limits.

For MCR coverage, the minimum Tier 1 share of the MCR is 320 and the Tier 2 ceiling is 80. The example has more than 320 units of eligible Tier 1 and can count no more than 80 of Tier 2 for MCR. Tier 3 is unavailable for MCR coverage. On these assumptions, the MCR numerator equals 700 + 80 = 780, producing a coverage ratio of 195 percent. These figures assume the regulatory definition of eligible Tier 1 applies to all 700 and that the categories are not reduced by further tests. They show why applying the SCR tier mix automatically to the MCR would be a category error.

Now consider the marginal effect of issuing a new 100-unit Tier 2 bond while holding every other amount and the SCR constant. Tier 2 rises from 550 to 650 gross, but the eligible Tier 2 amount in the illustrative SCR calculation remains 380 because the combined Tier 2/Tier 3 ceiling is binding. The SCR coverage ratio remains 120 percent. In a real issue, the transaction would also change assets, liabilities, expenses and potentially SCR; holding these constant is a deliberate controlled illustration to isolate the tier cap. It demonstrates that an extra €100 of correctly drafted debt can have zero marginal contribution to a specified regulatory numerator at an already binding limit.

If the insurer instead replaces 100 units of recognized Tier 2 with 100 units of genuinely qualifying unrestricted Tier 1, the admissible composition may improve. But the economic equivalence of the two securities cannot be assumed: ordinary equity bears a different residual claim and usually a different expected return, dilution and governance effect. The capital regulator's hierarchy and the investor's required return thus address related but distinct questions.

International Insurance Capital Standard

The IAIS completed an international standard aimed at group-wide comparability and supervision of internationally active insurance groups. The ICS adoption and implementation overview identifies a new phase following adoption in December 2024. The interactive Insurance Capital Standard sets out capital-resource eligibility, group valuation and supervisory calculations. The ICS operates through implementation and supervision; publication of an IAIS standard should not be reported as making identical legal instruments automatically eligible in every jurisdiction.

The ICS distinguishes resources by quality and features such as permanence, subordination, distribution discretion, and loss absorption. Group-level application introduces questions that may be less prominent when studying a single insurance company. Does a holding-company note bear losses in the right legal entity? Are proceeds actually available to regulated subsidiaries? Can local supervisors prevent upstream transfers? Does the consolidated capital numerator account for hybrid investments within the group without duplicate recognition?

The conceptual consistency of these questions is important, but numeric comparisons must use the actual ICS rules, versions and supervisory implementation rather than borrowing EU Solvency II limits. An EU Tier 2 label cannot be transplanted unchanged into the ICS computation. Conversely, a security structured for group-level ICS eligibility may not qualify identically for every operating insurer's local solo requirement.

United States: surplus notes and RBC

The U.S. surplus-note mechanism has a different statutory center of gravity. According to the NAIC surplus-note framework, such notes are unsecured and junior to all policyholder and other creditor claims; the domicile regulator must approve issuance and payments of principal and interest. Qualifying notes are reported as surplus under statutory accounting principles, rather than as the liabilities generally recognized for the same instruments under U.S. GAAP. The recognition responds to enforceable subordination and payment restrictions.

The NAIC risk-based-capital framework uses total adjusted capital and authorized control level RBC to assess intervention thresholds. RBC is explicitly a regulatory diagnostic and not a sufficient measure for ranking insurance undertakings or proving their entire financial security. Addition of a surplus note can affect statutory surplus and total adjusted capital under the governing rules, but underwriting risk, investment risk, credit risk, business risk and capital adjustments may also change.

A U.S. insurer's permission to pay a surplus-note coupon is not merely the equivalent of a European issuer deciding whether a coupon is economically attractive. It is a supervisory act in a legal framework placing policyholders first. Therefore pricing, default terminology, capital recognition and payment timing must be grounded in state-specific instruments and permission practices, not in an assumed universal subordinated-debt term sheet.

The international comparison is particularly informative for mutual insurers. The scholarly stock-versus-mutual capital comparison highlights differing access to external capital. A mutual's use of notes can give it a funding channel without issuing conventional voting equity. The benefits and costs still depend on regulatory acceptance, ultimate repayment obligation and the insurer's capacity to service the notes through adverse earnings cycles.

Solvency UK and forward-effective amendments

The United Kingdom's Solvency UK framework has its own rules and supervisory expectations following reforms of the inherited Solvency II structure. On February 25, 2026, the PRA published the CP4/26 own-funds consultation. This consulted on adjustments and clarifications; the publication itself was not a completed regulatory change.

The PRA issued Policy Statement PS18/26 on July 29, 2026, confirming final policy for proposal 1 concerning the treatment of certain recognized own-funds items and related reporting changes. Its own implementation section states that the relevant Own Funds and Group Supervision rule changes take effect on December 31, 2026. The present research date is November 15, 2026: this later effective date must be respected when interpreting what firms are currently required or permitted to do.

Similarly, the EU's Solvency II review overview places the principal new rules of Directive (EU) 2025/2 on January 30, 2027. A forward-dated regulation can be a crucial planning input for a security issued today, especially a thirty-year note, but is not evidence that the amended requirements already govern compliance calculations in November 2026. Transitional arrangements and eventual consolidated texts require their own effective-date analysis when a future actual transaction is tested.

The comparative lesson is chronological as well as jurisdictional. A statement that a bond “counts as Tier 2” must be accompanied by the named regime, balance-sheet entity, observation date and operative version of the relevant rules.

Group recognition and cross-border comparability

Consolidated solvency capital can conceal the location of financial resources. A group might report strong total own funds while a subsidiary writing long-term guarantees has limited access to capital held in another legal entity. Insurance supervisors therefore analyze the availability and transferability of group financial resources alongside their nominal quantity. Group capital rules also examine holding-company liabilities, intragroup financing, participations, minority interests and double gearing.

The research method should follow the actual funds: external investors pay the issuer; the issuer allocates proceeds; a downstream undertaking receives funded assets; the group accounts for internal transfers; each supervisor then applies recognition and fungibility rules. Distributing the same cash through multiple internal entities creates entries on several balance sheets, but does not thereby create an equal number of independent economic loss-bearing resources.

The IAIS group-capital standard and the EU Solvency II capital structure establish useful comparative reference points. Precise numerical mapping needs a bridge from each jurisdiction's definitions, including technical provisions, accounting valuation, own-funds adjustments, permitted capital instruments and tier limits. A simple ratio of reported capital to required capital across different regimes can obscure differences in both numerator and denominator.

For policyholders, the decisive question is whether an instrument contributes legally and economically available resources at the entity where covered claims are payable. For investors, the corresponding question is which legal entity actually owes payments and where their claim ranks if the business encounters losses. Examining these questions together identifies the real allocation of insurance-group financial risk.

Cost and Refinancing Risk

Pricing, cash flows and effective funding cost

The yield on an insurance hybrid security prices a bundle of promises and options. A lender receives scheduled distributions under conditions that may be materially more restrictive than those of senior debt, may face extended maturity if an issuer does not call, and may incur principal write-down or conversion. The observed spread over a benchmark yield therefore incorporates expected credit loss, compensation for liquidity and uncertainty, interest-rate reset risk, contractual option value and changing demand for securities recognized as insurance capital. A quoted yield is a market outcome, not a direct measure of the instrument's supervisory benefit.

An issuer's all-in economic cost begins with cash received at settlement and proceeds through issuance fees, coupon payments, any reset basis, hedging and collateral requirements, taxes, redemption costs and the value of flexibility retained by management. The internal rate of return on expected contractual cash flows provides one summary, but instruments with discretionary cancellation require a probabilistic or scenario-based distribution of cash flows rather than a single assumed path. Evaluating the capital benefit requires a corresponding measurement of how the proceeds alter eligible resources and financial resilience.

A simple ten-year illustration makes the dependence on assumptions visible. On €500 million of principal, a 4 percent coupon requires €20 million annually before other costs; a 6 percent coupon requires €30 million. The €10 million annual difference has a discounted present value of €77.217 million at a purely assumed 5 percent discount rate for ten payments. This figure makes no claim that market investors would accept either rate for otherwise identical securities. The relevant notes can differ in ranking, call structure, tenor and tax, each of which affects the comparison.

The contractual rate may reset after an expected call date. A note paying 4 percent until year ten and then three-month reference interest plus 300 basis points exposes the issuer to a different cash-flow path than a fixed coupon of 4 percent through legal maturity. The appropriate analysis uses forward interest-rate scenarios, a credit-spread curve, hedge effectiveness, transaction currency and the possibility of nonexercise of the issuer's call. A funding-cost comparison based only on the first coupon omits the component often responsible for refinancing pressure.

Credit spreads and embedded options

Subordinated creditors expect loss in states where senior creditors may remain whole, so priority produces a recovery difference even if the probability of firm-wide default were identical for both issues. Instruments allowing coupon cancellation can also experience payment reduction without a conventional missed-payment default. This makes a hybrid's spread sensitive to more than a simple probability of immediate liquidation.

The issuer's call resembles a contractual option that can be exercised when financing conditions and supervision permit. Investors commonly assess yield to first call alongside yield to maturity or perpetuity scenarios. Neither measure alone establishes the investor's realized yield. When interest rates fall, the issuer may wish to refinance at a lower cost and investors face reinvestment risk. When spreads rise, the issuer may retain the existing instrument, exposing investors to extension risk. If a coupon steps or resets, the incentive varies with the reset benchmark, issuer credit spread, tax costs and eligibility.

The observed initial coupon also incorporates the point in the market cycle when the security was issued. The 2025 public issuer examples discussed below display different coupons partly because they differ in currency, issue date, maturity, tier and contractual features. Those coupons cannot be ranked as a simple measure of which insurer is riskier. Even a pair of euro-denominated notes with similar face value may have materially different call dates or loss-absorption thresholds.

A more defensible empirical research design would match securities by currency, issue date or duration, security rank, first call, reset spread, issuer entity and broad market conditions, then analyze remaining yield differences with appropriate attention to liquidity. No such matched sample has been constructed in this monograph. The present case study remains documentary and comparative.

First-call expectations and refinancing cliffs

A refinancing cliff develops when a substantial portion of financing becomes economically or contractually relevant over a narrow interval. A security due in thirty years but first callable in ten years can place its earliest economically likely replacement around year ten, although no contractual repayment is promised on that date. Market stress can prevent efficient replacement, and supervisory approval can be withheld where redemption would undermine solvency.

An effective capital plan therefore compares the amount that is legally due within a horizon with the amount expected to be refinanced for economic or regulatory reasons. It also examines possible debt-market access at that date. A company can stagger call windows and maturities to reduce concentration while considering issuance costs, investor demand and existing capital eligibility. Such policies cannot remove the possibility that a broad sector shock closes insurance subordinated-debt markets precisely when issuers wish to replenish capital.

This mechanism can produce a feedback loop: insurers may seek to replace a note to preserve its regulatory eligibility or lower future coupon cost, while investors may demand higher spreads because they foresee weakening underwriting or investment earnings. Expected cheap replacement becomes less credible in the adverse states in which a capital buffer is most valuable. The regulator's insistence on issuer-option redemption and supervisory consent therefore reflects an economic goal of preserving permanence through stress.

Asset-liability management and liquidity stress

Insurer financial strength depends on the joint timing and risk characteristics of assets, insurance payments and financing cash flows. A subordinated note adds interest and principal obligations whose duration may be long, yet whose coupon reset and first call create earlier sensitivities. A life insurer's long-dated liabilities may coexist with asset reinvestment and policyholder surrender options; a property-casualty insurer may encounter immediate catastrophe claims and short-dated premium cycles. The same security can have different liquidity consequences for these different liability profiles.

A proper asset-liability analysis compares stressed asset realizations, investment income, policyholder claims, derivatives cash flows, collateral postings, subordinated coupons, other debt service and the ability to issue replacement capital. Subordinated interest can be deferred only where the instrument's legal conditions permit it. If an insurer is otherwise making a large collateral payment on interest-rate hedges, coupon flexibility may preserve cash, but neither creates hedging collateral nor assures prompt sale of investments without loss.

Currency also matters. A dollar note funding euro insurance exposures can create a direct exchange-rate mismatch unless hedged or matched against existing dollar assets. A cross-currency swap can reduce the first-order mismatch but introduces basis and counterparty effects. In stressed markets, margin collateral and the mark-to-market of the swap may affect short-term liquidity even while the long-run exchange-rate exposure is broadly hedged.

An integrated stress plan should identify the regulator's potential restrictions on distributions, the note's coupon mechanics, the insurer's actual liquidity management policy and the group's ability to transfer funds among entities. A capital instrument is not adequately analyzed when the stress model assumes that every permitted coupon deferral automatically solves a shortage of cash.

Agency incentives and capital-policy governance

Management chooses financing within a governance framework that may contain competing objectives. Shareholders may value the tax and return-on-equity consequences of debt, investors value contractual predictability, and supervisors emphasize the continued ability to pay policy claims. Managers may also seek to meet rating or market expectations at the least immediately visible cost. An apparently cheap bond can become expensive when its reset terms, loss of market access or supervisory restrictions are considered over the security's full life.

The Myers debt-incentive analysis indicates why debt can affect subsequent investment choices. The Cummins and Sommer insurer study reinforces the importance of modeling capital and risk policy jointly. These works support a critical question for insurance groups: whether management is financing a robust long-duration insurance franchise or attempting to support a risk position that may itself generate higher future capital requirements.

The answer needs a governance record. It should explain the issuance's use of proceeds, capital projections before and after the transaction, alternative financing sources, legal-entity allocation, planned calls and contingencies, and the insurance risk appetite that justifies the capital stack. For mutuals and other insurers with limited ordinary-share access, the stock-mutual capital structure evidence makes the issue especially relevant, though it does not determine a universal optimal mix.

Model risk and limits of inference

A model of subordinated financing can fail through mistaken legal classification, unrealistic call assumptions, a static view of SCR, inappropriate risk-free curves, poorly specified coupon-reset conventions, omission of tax effects and assumed capital fungibility across jurisdictions. It can also treat a market quote observed under favorable liquidity as a stable risk price. Each error changes either projected cash requirements or the amount the supervisor can recognize.

The appropriate response is explicit assumption management. Record the legal regime and its effective date, operating entity, issuer entity, priority ranking, regulatory classification, capital eligibility cap, market rate curve, coupon terms, permitted management actions, hedging treatment and stress horizon. Recalculate the outcome when one assumption changes. An outcome labeled “solvency benefit” should state whether it is a change in available capital, eligible own funds, SCR, MCR, a coverage ratio, cash liquidity or an investor-recovery measure.

The illustrative calculations in this work deliberately isolate mechanisms. They cannot estimate the true probability of a write-down, predict market spreads, test changes in insurer performance or prove that hybrid issuance caused a reduction in default risk. Each of those questions requires transaction-level legal evidence, market data, financial statements and an identification strategy beyond the current documentary design.

Comparative Issuance Cases

Selection, evidentiary scope and comparability

Four public insurance-group transactions in 2025 offer identifiable examples of capital raising through different subordinated terms. The selection is purposive rather than statistically representative: the issuers provide primary, openly accessible transaction announcements and cover several important instrument structures. Announcements establish described terms and management explanations, while any definitive legal interpretation of a trigger, guarantee or regulatory eligibility would require the underlying full offering documentation and supervising authority's treatment. Case comparisons therefore distinguish reported facts from the analysis derived from them.

The studies examine nominal proceeds, coupon and reset, legal maturity, first call, stated regulatory treatment, refinancing activity and investor exposures. Interest rates are quoted as described by the issuer, with no claim of common valuation dates or fully matched cash-flow characteristics.

AXA: restricted Tier 1 and dated Tier 2 in parallel

AXA's May 2025 capital placement offers an unusually clear same-issuer comparison. AXA announced €1 billion of perpetual, deeply subordinated restricted Tier 1 notes and €1 billion of dated Tier 2 notes due in 2055. The restricted Tier 1 security paid 5.750 percent until its specified December 2030 reset, with a nominal write-down mechanism activated on defined solvency triggers and distributions subject to AXA's discretion or mandatory restrictions. The Tier 2 issue paid 4.375 percent until its specified July 2035 reset and subsequently referenced three-month EURIBOR plus a margin.

The two instruments belonged to different risk-bearing layers of the same broad funding plan. AXA's public description reports restricted Tier 1 capital recognition for one and Tier 2 recognition for the other, within applicable limits. The difference between their announced fixed coupons is 1.375 percentage points, or 137.5 basis points. That difference is arithmetically exact for the two announced rates, but it is not a clean estimate of the compensation for Tier 1 write-down risk: the instruments have different call and reset dates, relative ranking, legal life and principal mechanisms.

The announcement also says proceeds were intended for general corporate purposes, including refinancing part of outstanding debt. This supports an interpretation of the transaction as a deliberate mix of capital tiers and financial-liability management. It does not establish how much of the €2 billion ultimately became additional eligible consolidated own funds after offsetting existing redemptions and eligibility limits.

Allianz: subordinated placement with a tender offer

Allianz SE reported a €1.25 billion subordinated placement with maturity in July 2055, a first issuer call from January 2035, and a 4.431 percent fixed annual coupon until July 2035 before a floating-rate period. The announcement also reports a €647 million tender buyback of an earlier €1.5 billion subordinated bond bearing 2.241 percent and subject to a call beginning in July 2025, leaving €853 million of the older issue outstanding.

This is direct evidence that an insurance group can coordinate new debt issuance with partial retirement of an existing tranche. The new issue size exceeds the repurchased principal amount by €603 million, but that arithmetic alone is not a measure of net eligible own-funds improvement. The actual effect depends on both instruments' regulatory recognition, remaining maturities, issuance expenses, eligible limits and how proceeds are deployed.

The transaction also demonstrates why coupon comparisons across successive market cycles require caution. Replacing a lower-coupon legacy security with a higher-coupon new instrument can raise nominal debt service while extending contractual maturity or changing supervisory treatment. A rational refinancing decision cannot be inferred from coupon reduction as the sole objective.

Generali: a shorter-dated Tier 2 placement

On June 11, 2025, Generali announced a €500 million Tier 2 bond due June 18, 2036, with an annual coupon of 4.135 percent, a reported mid-swap spread of 155 basis points and an expected settlement date of June 18, 2025. The issue was offered through Generali's euro medium-term note program. Its orderbook exceeded €1.35 billion, more than 2.7 times the stated issuance size, according to the issuer.

The orderbook is evidence of recorded subscription interest at the announced terms, not a guarantee of secondary-market liquidity or an independent market valuation of insurer risk. The shorter legal maturity contrasts with the long-dated 2055 instruments announced by AXA and Allianz. The responsible analytical comparison therefore takes account of tenor, call structure, credit environment and issuer differences rather than interpreting the lowest disclosed coupon as the least costly security on every relevant dimension.

Management cited maturity-profile management and cost efficiency as motivations. Those are public statements of corporate purpose. Evaluating their success would require actual post-transaction debt-service costs, redeemed amounts, eligibility results and later financial reports, none of which is inferred from this announcement alone.

Zurich: U.S. dollar dated subordinated debt

Zurich Insurance Group's May 2025 placement announcement describes USD 750 million of dated subordinated notes issued by Zurich Finance (Ireland) II DAC. The notes mature in November 2055, are first callable in May 2035, and pay a fixed annual coupon of 6.25 percent until November 2035. The transaction was aimed at institutional investors in European and Asian markets and described as being for general corporate purposes.

This transaction brings two additional considerations into focus. First, a finance-company issuer necessitates examination of the legal obligations of any supporting group entities and the allocation of proceeds before asserting the location of loss-bearing capital. Second, a U.S. dollar coupon cannot be compared directly with contemporaneous euro coupons without adjusting for currency-specific yield curves, cross-currency hedging, tenor, issue timing and contractual differences.

The announcement is a primary source for issue size, currency, identified issuer, coupon, call and maturity. It is not sufficient evidence by itself to classify every group and subsidiary level of the notes' regulatory recognition or to state their contractual recovery in insolvency. Those judgments require the final terms and applicable supervisory rules.

Cross-case analytical synthesis

Issuer and announcement Stated amount Disclosed initial coupon Maturity or permanence Principal analytical distinction
AXA restricted Tier 1, May 2025 €1.0 billion 5.750% Perpetual Principal write-down and discretionary coupon
AXA Tier 2, May 2025 €1.0 billion 4.375% 2055 Dated Tier 2, later benchmark-linked coupon
Allianz, April 2025 €1.25 billion 4.431% July 2055 Long dated, partial buyback of older subordinated notes
Generali, June 2025 €0.5 billion 4.135% June 2036 Shorter contractual term and disclosed orderbook
Zurich, May 2025 USD 0.75 billion 6.250% November 2055 Dollar denomination and finance-company issuance

Amounts, initial coupons, issuer labels and dates in the table are taken from the AXA offering statement, the Allianz transaction statement, the Generali placement statement, and the Zurich placement statement. The figures are historical announcement data, not a cross-sectional estimate of comparable market yields or net incremental regulatory capital.

The transactions show at least five dimensions of heterogeneity: regulatory tier, permanence, coupon reset, issuer legal entity and intended use of proceeds. They also reveal why an evaluation of individual securities should combine contract inspection and balance-sheet context. AXA's two-tier issuance illustrates distinct types of loss absorption within one funding program. Allianz's concurrent tender emphasizes rollover and maturity management. Generali's issue displays a shorter legal term and reported investor subscription. Zurich's dollar placement exposes the cross-currency and legal-entity dimensions.

The evidence supports an interpretation of subordinated securities as flexible components of insurer funding strategies subject to legal and supervisory design constraints. It does not support an issuer ranking based on initial coupons, nor does it establish the extent to which any transaction caused a subsequent improvement in insurer solvency.

Implications for insurer types and research

A stock insurer with reliable access to ordinary equity has a different menu of financing options from a mutual or closely held insurer. A reinsurer facing concentrated catastrophe exposure can have different stress liquidity needs from a life insurer with long-duration policies. An international group with many regulated subsidiaries has a different capital-transfer problem from a single licensed domestic insurer. These distinctions imply that a common list of contract terms can be used for comparative analysis while the economically relevant stress tests must be specialized to the insurer's actual risks.

The main institutional implication is that capital issuance policy should include a versioned contract and supervisory map. Each proposed note should be assessed in four linked records: its contractual promises and potential changes; its local eligible capital effect; its consolidated or holding-company effect; and its liquidity and refinancing outcomes across representative insurance risk scenarios. Such records draw on existing law and risk management practice; they constitute a practical analytical organization of evidence rather than a new named theory.

Future research can test capital-security pricing with matched issue-level data, evaluate whether coupon deferrals correlate with subsequent underwriting or investment losses, and examine the effect of regulatory reforms on instrument supply. These projects demand comprehensive securities filings, granular solvency disclosures and explicit identification of treatment and comparison groups. The historical announcement examples here are a suitable starting catalog, not a substitute for that empirical work.

Conclusion

Subordinated debt and hybrid capital are significant in insurance because the contract determines both funding obligations and the sequence through which adverse outcomes reach different financial stakeholders. Their supervisory value is grounded in enforceable subordination, adequate permanence, permitted distribution flexibility, principal loss absorption where required, and eligibility within the relevant regulatory limits. The ability to issue a security and the ability to count its entire face value toward a particular solvency requirement are separate questions.

The European framework demonstrates this through distinct qualitative requirements and SCR/MCR tier ceilings. The IAIS Insurance Capital Standard introduces group-wide recognition and cross-entity availability questions without superseding domestic implementation. U.S. surplus notes rely on statutory surplus treatment and direct state-commissioner permission for both issuance and payments. Solvency UK's 2026 policy process confirms that the date a supervisory decision becomes effective matters when comparing actual compliance. Accounting classification under IAS 32 further confirms that a prudential capital item need not have an identical label in published financial statements.

The financial consequences are equally specific. Coupon cancellation can preserve liquidity when it is legally available, while cumulative deferral can carry forward claims. Principal write-down can shift losses to junior investors before insolvency under the applicable contract. Subordination in liquidation protects senior claimants only within the recoverable assets and legally applicable priorities. A future call is an option rather than a promised repayment; refinancing stress can turn economically attractive issuance into expensive or extended funding. Asset-liability mismatch and holding-company structure determine whether apparent capital strength translates into resources accessible to an individual insurer.

The public 2025 transactions of AXA, Allianz, Generali and Zurich illustrate this variety without furnishing a statistically valid basis for issuer comparison. Their nominal amounts and stated coupon rates are reliable descriptors of announced transactions, while conclusions about net eligible capital, precise investor recovery, causal impact and comparative risk require further evidence.

The original analytical result of the monograph is a source-grounded integration of the instrument's legal waterfall, state-dependent payment mechanisms, prudential numerator and cap, group-entity availability, and financing cash flows. These elements must be reconciled using a common transaction date and regulatory version whenever a claim of solvency benefit is made. Policyholder security ultimately concerns the availability of claims-paying resources through adverse states, and the investor's required compensation reflects the specific junior claims relinquished to make that protection possible.

The research has defined limits. The quantitative examples are hypothetical and fully stated, the four transactions are selected issuer announcements, certain regulatory portals intermittently rate-limit automated access, and scholarly studies with restricted full text are used only to the extent supported by their publisher records and abstracts. No original market dataset, causal estimation, final-prospectus legal audit, external peer review or public release is represented here. The scientific argument consists of the verified legal, financial and comparative relationships stated above.

References

  • European Insurance and Occupational Pensions Authority. (2026 access). Solvency II Single Rulebook: Delegated Regulation (EU) 2015/35, Article 71, Tier 1 features determining classification. Document or publisher record

  • European Insurance and Occupational Pensions Authority. (2026 access). Solvency II Single Rulebook: Delegated Regulation (EU) 2015/35, Article 73, Tier 2 basic own-fund features. Document or publisher record

  • European Insurance and Occupational Pensions Authority. (2026 access). Solvency II Single Rulebook: Delegated Regulation (EU) 2015/35, Article 82, Eligibility and limits applicable to Tiers 1, 2 and 3. Document or publisher record

  • European Insurance and Occupational Pensions Authority. (2026 access). Solvency II Single Rulebook: Delegated Regulation (EU) 2015/35, Article 69, Tier 1 basic own-fund items. Document or publisher record

  • European Insurance and Occupational Pensions Authority. (2026 access). Solvency II Single Rulebook: Delegated Regulation (EU) 2015/35, Article 72, Tier 2 basic own-fund items. Document or publisher record

  • European Insurance and Occupational Pensions Authority. (2026 access). Solvency II Single Rulebook: Delegated Regulation (EU) 2015/35, Article 74, Tier 2 ancillary own-fund items. Document or publisher record

  • International Association of Insurance Supervisors. (2024). Insurance Capital Standard, adopted December 2024; ICS Online Tool, accessed November 15, 2026. Document or publisher record

  • International Association of Insurance Supervisors. (2026 access). Insurance Capital Standard: standard-setting and implementation overview. Document or publisher record

  • National Association of Insurance Commissioners. (2025, January 9). Surplus Notes. Insurance Topics. Document or publisher record

  • National Association of Insurance Commissioners. (2026, June 30). Risk-Based Capital. Insurance Topics. Document or publisher record

  • Bank of England, Prudential Regulation Authority. (2026, July 29). PS18/26, Solvency UK: Post-implementation reporting and disclosure amendments and Own Funds permissions update. Document or publisher record

  • Bank of England, Prudential Regulation Authority. (2026, February 25). CP4/26, UK Solvency II Own Funds: Updates and fixes to rules and expectations. Document or publisher record

  • IFRS Foundation, International Accounting Standards Board. (2026 access). IAS 32: Financial Instruments: Presentation. Document or publisher record

  • European Parliament and Council. (2009). Directive 2009/138/EC on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II), OJ L 335. Document or publisher record

  • European Insurance and Occupational Pensions Authority. (2026 access). Solvency II: regulation and policy overview, including Directive (EU) 2025/2 application date. Document or publisher record

  • AXA. (2025, May 28). AXA announces the placement of Euro 1 billion Restricted Tier 1 Notes and Euro 1 billion Tier 2 Notes. Document or publisher record

  • Allianz SE. (2025, April 1). Allianz concludes placement and partial buyback of subordinated bonds. Investor Relations. Document or publisher record

  • Assicurazioni Generali S.p.A. (2025, June 11). Generali successfully placed €500 million subordinated bond. Press release. Document or publisher record

  • Zurich Insurance Group Ltd. (2025, May 15). Zurich announces successful placement of USD 750 million of dated subordinated debt. Document or publisher record

  • Cummins, J. David, and David W. Sommer. (1996). Capital and risk in property-liability insurance markets. Journal of Banking & Finance 20(6), 1069–1092. DOI: 10.1016/0378-4266(95)00044-5. Document or publisher record

  • Myers, Stewart C. (1977). Determinants of corporate borrowing. Journal of Financial Economics 5(2), 147–175. DOI: 10.1016/0304-405X(77)90015-0. Document or publisher record

  • Harrington, Scott E., and Greg Niehaus. (2002). Capital Structure Decisions in the Insurance Industry: Stocks versus Mutuals. Journal of Financial Services Research 21, 145–163. DOI: 10.1023/A:1014329903079. Document or publisher record